Ipilimumab vs Ondansetron

## Ipilimumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Ondansetron**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Ondansetron**: Selective 5-HT3 receptor antagonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Ondansetron — 3-5 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Ondansetron — C18H19N3O.

**Molecular Weight**: Ipilimumab — N/A; Ondansetron — 293.3660 g/mol.

**Type**: Ipilimumab — Antibody; Ondansetron — Small molecule.